Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy

Published:2024-01-08 Issue:1 Volume:13 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zheng Ying¹²,Lebid Andriana¹²,Chung Liam¹²,Fu Juan¹²,Wang Xiaoxu¹²,Otrocol Andrea¹²,Zarif Jelani C.¹²,Yu Hong¹²,Llosa Nicolas J.¹²,Pardoll Drew M.¹²

Affiliation:

1. Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Funder

School of Medicine

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2297503

Reference37 articles.

1. Activins and Inhibins in Endocrine and Other Tumors

2. ALK7, a Receptor for Nodal, Is Dispensable for Embryogenesis and Left-Right Patterning in the Mouse

3. Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity

4. Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation

5. Inhibin at 90: From Discovery to Clinical Application, a Historical Review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ag85B-ENO146-82 therapeutic vaccines enhance anti-tumor immunity by inducing CD8+ T cells and remodeling tumor microenvironment;International Immunopharmacology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3